Sleep Schedules Modifications in Sleep Apnea Patients Treated by nCPAP
NCT ID: NCT01355419
Last Updated: 2015-05-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2010-08-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea
NCT00929175
Efficacy of CPAP Treatment on Blood Pressure of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome
NCT01508754
Effects of CPAP Therapy on Blood Pressure and Heart Rate Variability in Obstructive Sleep Apnea
NCT04712656
Effects of Continuous Positive Airway Pressure (CPAP) in Patients With Resistant Hypertension and Obstructive Sleep Apnea (OSA)
NCT00812695
Effect of CPAP vs Control on Nocturnal Dipping in Normotensive Patients With Obstructive Sleep Apnea
NCT04938128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sleep schedules on mid term periods in OSA patients under CPAP therapy has not been studied. The investigators have planned to study sleep schemes before and after CPAP therapy in moderate to severe sleepy OSA patients. Sleep schemes and physical activity will be studied with actigraphy.
Study Design : prospective study. Number of patients supposed to be studied: 190
Methods:
Patients Ø OSA patients assessed by polysomnography, showing apnea-hypopnea index \> 20, and Epworth Sleepiness Scale Score(ESS) \>10 Ø Indication of CPAP therapy
Initial Evaluation :
* Phase 1
* ESS
* BMI
* Questionnaire : Nottingham health profile
* Comorbidities -medical therapy
* Smoking/alcohol Consumption
* Then, we give an Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days
* Phase 2
* Actigraphy report
* Start of CPAP therapy(pressure adjusted according to autoCPAP device report after minimum one night)
Second Evaluation, after 3 months under CPAP:
* Phase 1
§ ESS
* BMI
* CPAP observance report to calculate mean use/day
* Questionnaire : Nottingham health profile
* Actigraph (Body Media Sense WearÒ) to the patients, that he has to wear during 7 complete days
* Phase 2: after 1 week under CPAP and actigraphy
* Actigraphy report
* CPAP observance report
* CPAP Tolerance Questionnaire Ø
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
obstructive sleep apnea, CPAP
moderate to severe obstructive sleep apnea requiring CPAP therapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* sleepy (sleepiness assessed by Epworth Sleepiness Scale)
* indication for CPAP therapy
Exclusion Criteria
* age \< 18
* non sleepy Moderate to severe OSA
* no CPAP treatment required
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Saint Pierre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie Bruyneel
chef de clinique adjoint
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie Bruyneel, MD
Role: PRINCIPAL_INVESTIGATOR
CHU St Pierre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU St Pierre
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AK/10-07-45/3912
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.